Equity Analysis

Company Profile

Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets

Company News

Piramal Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543635

INE0DK501011

52.9497872

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

PPLPHARMA

40.27

27655.11

EPS(TTM)

Face Value()

Div & Yield %:

5.18

0.05

Back

Kabra Commercial reports standalone net profit of Rs 0.38 crore in the December 2024 quarter

Feb 08,2025

Net profit of Kabra Commercial reported to Rs 0.38 crore in the quarter ended December 2024 as against net loss of Rs 0.02 crore during the previous quarter ended December 2023. Sales rose 81.70% to Rs 9.63 crore in the quarter ended December 2024 as against Rs 5.30 crore during the previous quarter ended December 2023.

Particulars	Quarter Ended
	Dec. 2024	Dec. 2023	% Var.
Sales	9.63	5.30	82
OPM %	24.20	-3.77	-
PBDT	1.32	0	0
PBT	1.31	-0.01	LP
NP	0.38	-0.02	LP